High-dose IL-2 therapy was initially used to treat cancers such as renal cell carcinoma or melanoma, given that, when administered in high doses, IL-2 promotes the expansion and survival of Teffs.56 This evidence concerns the gene IL2 and hereditary clear cell renal cell carcinoma.